Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

Enjoyed your post as usual. Especially this part.
Have a good weekend !

The exciting part, if any of this is remotely true, is that substantial ELTP revenue from generic OxyContin is not 3 years away but more like 3 months away. This week's PR shows that Elite is ready, and all it will take is the word GO and a flip of a switch.


OXYCONTIN = $3 BILLION/YR
Generics could cut it down by half... $1.5 BILLION
Give half to brand-names... $750,000,000

That leaves 3-5 generic competitors to split $1+ billion dollars over 18 months and possibly starting very soon. FDA repeatedly has said they want more generic ADFs. We're about to find out if they really mean it.